One year of 3TC therapy in hepatitis e antigen (HBeAg)-positive patients may achieve alanine aminotransferases (ALT) normalization, HBeAg loss, and improved liver fibrosis in up to 70%, 30%, and 60% of patients, respectively [1]. The gene discussed is GPT; the disease is Hepatic fibrosis.